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Low-Affinity Ligands for the TCR Drive
Proliferation of Mature CD81 T Cells
in Lymphopenic Hosts
and CD41 T cells. Recently it has been shown that naive
CD81 T cells rapidly disappear in MHC class I±deficient
hosts (Tanchot et al., 1997a; Nesic and Vukmanovic,
1998; Freitas and Rocha, 1999). While CD41 T cells are
able to survive for a longer time in the absence of MHC
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class II expression, they also demonstrate a dependence
on MHC class II for prolonged survival (Takeda et al., 1996;
Brocker, 1997; Kirberg et al., 1997; Rooke et al., 1997).Summary
This MHC dependence is specific, as both CD81 and CD41
T cells require the restricting MHC allele for survival. TheseIn the absence of thymic emigration, the peripheral T
data suggest that ongoing TCR ligation is required forcell pool is maintained by division of mature lympho-
survival of naive T cells in the periphery. The peptide speci-cytes. We have examined the molecular interactions
ficity of this interaction is of much interest.required for peripheral CD81 T cell expansion in lympho-
Many studies have described the ability of mature Tpenic mice without conventional antigenic stimulation.
cells to divide spontaneously in the periphery of lympho-Expansion of CD81 T cells in lymphopenic hosts was
penic hosts. It has been shown that following transferfound to be peptide specific. An antagonist peptide
into SCID or nude mice, T cells divide slowly, resultingknown to serve as a ligand for positive selection of
in the expansion of the peripheral lymphocyte poolthese T cells promoted expansion; however, a con-
(Bell et al., 1987, 1989; Rocha et al., 1989; Pereira andtrol peptide that binds the same class I molecule did
Rocha, 1991; Sprent et al., 1991; McDonagh and Bell,not. Surprisingly, the cells undergoing proliferation in
1995; Bruno et al., 1996). Similarly, transfer of T cellslymphopenic hosts did not mature to cytotoxic ef-
into sublethally irradiated or RAG-deficient hosts resultsfectors and displayed a partially activated surface phe-
in proliferation of the transferred cells (Oehen andnotype. These data suggest that division of T cells in
Brduscha-Riem, 1999). Furthermore, estimates of thy-the periphery of lymphopenic hosts requires specific
mic output do not fully account for either the level of Trecognition of self-peptide/MHC complexes, similar to
cell turnover in the periphery or for all of the T lympho-the signal for thymocyte maturation.
cytes that contribute to peripheral reconstitution follow-
ing severe lymphocyte depletion (Scollay et al., 1980;Introduction
Bell et al., 1987, 1989; Rocha et al., 1989; Bell and Spars-
hott, 1997). The mechanism that drives the expansionDuring thymocyte maturation, T cells are selected for
of peripheral T cells is not well understood. It has been
their ability to interact productively with self-MHC and
speculated that expansion is due to encounter with anti-
their inability to recognize self with high affinity (Jame-
gen or growth factors; however, recent evidence also
son et al., 1995). Low-affinity interactions between the suggests that this division may be independent of cog-
TCR and self-peptide/MHC complexes deliver a signal nate antigen yet involve interactions with self-peptide/
to developing thymocytes that promotes both survival MHC (Bruno et al., 1996; Mackall et al., 1996; Bell and
and maturation (Allen, 1994; Alam et al., 1996, 1999). Sparshott, 1997; Ernst et al., 1999 [this issue]; Oehen
The result of this process is a naive T cell population and Brduscha-Riem, 1999; Viret et al., 1999).
that is self-MHC restricted and tolerant. T cells leave the In this study, we directly address the specificity of the
thymus and populate the secondary lymphoid organs, TCR interaction with self-MHC that is required for cell
joining the peripheral T cell pool that consists of both division in a depleted lymphoid compartment. We trans-
naive and memory T cells. ferred mature CD81 OT-1 TCR T cells, which recognize
Even in the absence of thymic output, peripheral ho- an ovalbumin-derived peptide in the context of H2-Kb
meostatic mechanisms maintain the pools of both naive (Hogquist et al., 1994), into mice expressing wild-type
and memory T cell subsets (Sprent et al., 1991; von levels of MHC class I or into TAP-deficient mice express-
Boehmer and Hafen, 1993). Without overt antigen expo- ing low levels of MHC class I. To assess the role of
sure, both naive and memory T cells divide in the periph- specific peptides in this process, we utilized as hosts
ery. Memory cells divide rapidly, and naive T cells divide transgenic mice expressing single H2-Kb binding pep-
less frequently while maintaining a naive phenotype tides with different affinities for the OT-1 TCR that are
(Tough and Sprent, 1994). Peripheral T cells have a great independent of TAP8 function for presentation. Our re-
potential for expansion and can divide many times in sults imply that peripheral T cell expansion is dependent
empty lymphoid compartments in the absence of cog- upon peptide-specific, low-affinity interactions similar
nate antigen (Bell et al., 1987, 1989; Rocha et al., 1989; to those required for positive selection in the thymus.
Pereira and Rocha, 1991; Sprent et al., 1991; McDonagh
and Bell, 1995; Bruno et al., 1996). Results
The survival of mature T cells in the periphery clearly
involves a MHC-dependent signal for both naive CD81 Expansion of Peripheral CD81 T Cells in Lymphopenic
Hosts Is Impaired in TAPo Hosts
Upon transfer into irradiated or lymphopenic syngeneic* To whom correspondence should be addressed (e-mail: mbevan@
u.washington.edu). hosts, both CD41 and CD81 T cells divide and persist
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An Antagonist Ligand Restores Proliferation
in TAPo Hosts
To determine the peptide specificity of the TCR-MHC
class I±mediated interaction that promoted the expan-
sion of OT-1 CD81 T cells, we utilized transgenic mice
expressing different MHC class I±binding peptides. The
transgenic peptides were expressed as fusion proteins
with an amino-terminal endoplasmic reticulum insertion
signal sequence (ss). This strategy has previously been
shown to allow TAP-independent loading and presenta-
tion of MHC class I±binding peptides (Bacik et al., 1994).
Three lines of transgenic mice were generated, each
expressing a peptide that interacts with the OT-1 TCR
with different affinity when bound to H2-Kb (Alam et al.,
1996, 1999). The ss-OVAp line expresses an agonist
peptide that is the cognate ligand for the OT-1 TCR
Figure 1. Proliferation of Donor Cells in Lymphopenic Hosts Is MHC (Hogquist et al., 1994). The ss-R4 line expresses an
Class I Dependent antagonist peptide for the OT-1 TCR that is a low-affinity
CD81 T cells were enriched from pooled spleen and lymph node of ligand which antagonizes cytolytic activity of OT-1 CTL
OT-1 or OT-1 Thy1.11 mice, labeled with CFSE, and 2 3 106 and promotes positive selection of the OT-1 TCR in fetal
CD81Va21 cells were injected per recipient. Splenocytes from hosts thymic organ culture (Jameson et al., 1993; Hogquist et
were analyzed 5 days after transfer for detection of CFSE1 donor
al., 1994). The ss-VSV line expresses a control H2-KbOT-1 cells by staining with anti-CD8 and anti-Va2.
binding peptide derived from vesicular stomatitis virus(A) CFSE expression is shown for OT-1 CD81Va21 cells transferred
that binds Kb similarly to OVAp and R4 but does notinto unirradiated B6, irradiated B6, or irradiated TAP8 hosts. Similar
results were observed with OT-1 RAG8 donor cells and on days 3 measurably interact with the OT-1 TCR (Fremont et al.,
and 6 post transfer in irradiated hosts. 1995; Alam et al., 1996).
(B) CFSE expression is shown for OT-1 Thy1.11 CD81Va21 cells Transgenic founders were bred onto the TAP8 back-
transferred into untreated B6, Thy1.2-depleted B6, or Thy1.2-
ground. Expression of the ss-peptide transgenes indepleted TAP8 hosts.
TAP-deficient mice did not result in detectable upregula-
tion of surface levels of Kb molecules compared to TAP8
littermates (Figure 2A). Furthermore, cells from ss-pep-
tide transgenic mice did not stain with the OVAp-Kb(Bell et al., 1987, 1989; Rocha, 1989; Pereira and Rocha,
complex specific monoclonal antibody, which cross re-1991; Sprent et al., 1991; McDonagh and Bell, 1995;
acts with R4-Kb (data not shown) (Porgador et al., 1997).Bruno et al., 1996). To assess the MHC requirements for
To test for presentation of the ss-peptides by Kb on theCD81 T cell proliferation, we used OT-1 TCR (Va21Vb51)
surface of transgenic cells, splenocytes from ss-R4 and
transgenic CD81 T cells, which were labeled with the
ss-VSV transgenic mice were used to stimulate prolif-
cytosolic fluorescent dye CFSE. Labeling with CFSE
eration of either R4 or VSV peptide-specific CTL. Both
allows the identification of donor cells and the quantita-
R4- and VSV-specific CTL lines proliferated in reponse
tion of donor cell proliferation by decreasing CFSE fluo- ss-R4 and ss-VSV transgenic cells, respectively, but
rescence with each division. Labeled cells were trans- not to transgene negative controls, showing that the
ferred into control MHC class I±positive hosts or MHC transgenes are expressed and that the peptides are
class I±low hosts (TAP8), which were irradiated (Figure presented by Kb in these mice (Figure 2B). These data
1A) or T cell depleted by treatment with anti-Thy1.2 indicate that the ss-R4 and ss-VSV transgenes are pre-
antibody (Figure 1B). When transferred into untreated senting the transgenic peptides on the cell surface,
B6 hosts, the OT-1 CD81 T cells did not measurably though at low levels. These transgenic peptides are pre-
divide, as indicated by a single CFSE peak of Va21CD81 sumably presented along with the low levels of self-
cells. Cells transferred into irradiated or T cell±depleted peptides bound to the MHC class I found on TAP8 cells.
B6 hosts proliferated, with the majority of transferred We next used ss-peptide-TAP8 mice as recipients for
cells having divided at least once 5 days following trans- CFSE-labeled OT-1 CD81 T cells to determine if interac-
fer (Figure 1). The proliferation was not due to a side tions between the OT-1 TCR and specific peptide/MHC
effect of irradiation, as similar results were obtained complexes could restore the proliferation of donor cells
in T cell±depleted hosts (Figure 1B). Interestingly, no in irradiated TAP8 hosts. OT-1 CD81 T cells were trans-
significant division was observed following transfer into ferred into irradiated ss-VSVTAP8, ss-R4TAP8, ss-OVAp
irradiated or T cell±depleted TAP8 hosts, showing that TAP8, or TAP8 hosts (Figure 3). No division was observed
division of CD81 T cells in lymphopenic hosts is impaired among Va21CD81 donor cells in the ss-VSV TAP8 or
in the absence of TAP8 function. We hypothesized that TAP8 hosts. No proliferation was observed in a second
the inability of OT-1 CD81 T cells to proliferate in irradi- ss-VSV transgenic line (data not shown). As expected,
ated TAP8 hosts could be due to the decreased levels extensive proliferation was observed when OT-1 CD81 T
of surface MHC class I or, alternatively, the limited reper- cells were transferred into mice expressing the cognate
toire of self-peptides bound to MHC class I on TAP- antigen (ss-OVAp), as indicated by a total loss of CFSE
deficient cells. As MHC class I appeared to be crucial label and the fact that greater than 70% of the spleno-
in this proliferation, we became interested in the speci- cytes were Va21CD81 (data not shown). Surprisingly,
significant division was observed by cells transferredficity of MHC recognition in this process.
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Figure 3. Proliferation of OT-1 CD81 T Cells in Irradiated TAP8 Hosts
Is Restored by Expression of an Antagonist Peptide
Donor cells were pooled spleen and lymph node from OT-1 (A) or
OT-1 RAG8 mice (B). CD81Va21 CFSE-labeled cells (2 3 106) were
Figure 2. Expression of ss-Peptide Transgenes injected per indicated host. CFSE expression is shown for
(A) Expression of H-2Kb is not upregulated in TAP8 mice expressing CD81Va21 cells from spleen on day 5 (A) or day 6 (B) post transfer.
ss-peptide transgenes. Expression levels of the MHC class I mole- Data are representative of at least five experiments.
cule Kb were compared on splenocytes from ss-OVApTAP8 (thin
black line), ss-R4TAP8 (dashed line), ss-VSVTAP8 (dotted line), TAP8
(bold gray line), and B6 (bold black line) mice.
due to previously undescribed agonist properties of this(B) ss-peptide transgenic APC stimulate proliferation of peptide-
peptide. R4, a single amino acid variant of the cognatespecific CTL. Filled symbols represent ss-peptide transgene posi-
tive and open symbols represent control transgene negative APC. ligand OVAp, has previously been shown to be a pure
R4-specific CTL were incubated with ss-R4TAP8 (filled triangles) antagonist of OT-1 CTL activity with no agonist proper-
and control TAP8 (open triangles) splenocytes (left panel). VSV-spe- ties (Jameson et al., 1993; Barnden et al., 1994). R4 also
cific CTL were incubated with ss-VSV (filled circles) and control B6 efficiently promotes positive selection of OT-1 thymo-
(open circles) splenocytes (right panel). Peptide-specific CTL (5 3
cytes in fetal thymic organ culture without inducing any104) were cultured with increasing numbers of irradiated APC for 72
deletion of developing thymocytes (Hogquist et al.,hr and were pulsed with [3H]thymidine for 18 hr.
1994). To examine further the capacity of the R4 peptide
to interact with the OT-1 TCR, we tested the ability ofinto ss-R4TAP8 hosts of two different transgenic founder
high concentrations of the R4 peptide to stimulate prolif-lines (Figure 3). The proliferation observed by cells trans-
eration or lysis by OT-1 T cells (Figures 4A and 4B).ferred into ss-R4TAP8 hosts was similar to that observed
Freshly isolated OT-1 splenocytes proliferated in re-
in B6 hosts (Figure 1), with much less division than anti-
sponse to concentrations of OVAp as low as 10 pM. No
gen-stimulated cells (Figure 3). No differences were ob- proliferation was observed to the R4 peptide at concen-
served between OT-1 RAG1 (Figure 3A) and OT-1 RAG8 trations as high as 10 mM (Figure 4A). Similarly, OT-1
(Figure 3B) CD81 donor cells. Thus, proliferation of OT-1 CTL lysed targets coated with 1 pM concentrations of
T cells in TAP8 hosts can be restored by the addition OVAp but did not lyse targets at any concentration of
of a single Kb-binding antagonist peptide without upreg- R4 (Figure 4B).
ulating class I levels (Figure 2). Significantly, this prolifer- To assure that the ss-R4 transgenic peptide was not
ation was mediated by a TCR interaction that is peptide different from the exogenously added synthetic pep-
specific; no signal is provided by VSV, a control peptide tide and therefore able to mediate antigenic stimuli of
that binds and stabilizes Kb similarly to R4 but does OT-1 T cells, irradiated splenocytes from the different
not interact with the OT-1 TCR, or in TAP8 mice, which ss-peptide transgenic mice were used as stimulators in
display a similar low level of self-peptides/MHC class I a proliferation assay (Figure 4C). OT-1 splenocytes prolif-
complexes. R4, an antagonist of the OT-1 TCR, can deliver erated strongly to ss-OVApTAP8 antigen-presenting
a signal for in vivo proliferation, suggesting that weak, cells (APC) but did not proliferate to either ss-R4TAP8
low-affinity interactions promote division in lymphopenic or ss-VSVTAP8 APC, suggesting that irradiation did not
hosts in the absence of conventional antigenic stimulation. induce the transgenic APC to be antigenic. Also, we
found that when Con A blasts generated from the ss-
R4 Is Not an Agonist for Proliferation or Lysis peptide mice were used as targets for OT-1 CTL, only
by OT-1 CD81 T Cells In Vitro ss-OVAp blasts were lysed (Figure 4D). Hence, the cells
We next wanted to determine if the ability of R4 to induce expressing the transgenic ss-R4 peptide did not stim-
ulate OT-1 cells in vitro. Furthermore, OT-1 cells didproliferation of OT-1 CD81 T cells in irradiated hosts is
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Figure 5. Surface Phenotype of CD81 T Cells Proliferating in Various
HostsFigure 4. Exogenous R4 and ss-R4 Transgene-Expressing Cells Do
Not Stimulate Proliferation or CTL Targeting by OT-1 CD81 T cells CD81Va21 cells (2 3 106) from OT-1 RAG8 mice were CFSE labeled,
injected into irradiated hosts, and splenocytes were analyzed 6 days(A) OT-1 splenocytes were cultured with OVAp (circles), R4 (dia-
post transfer.monds), or VSV (squares) peptides and irradiated B6 splenocytes
(A) This panel shows Va2 versus CFSE levels for CD81 cells trans-and were pulsed with [3H]thymidine for 6 hr after 36 hr of culture.
ferred into irradiated TAP8, B6, ss-R4TAP8, and ss-OVApTAP8 hosts.(B) OT-1 CTL were used at 10:1 effector to target ratio with OVAp
(B) This panel compares levels of activation markers on the trans-(circles), R4 (diamonds), or VSV (squares) peptide coated and EL4
ferred OT-1 CD81 T cells. Donor cells were gated on CD81Va21target cells.
from TAP8 (bold gray line), B6 (thin black line), ss-R4TAP8 (dotted(C) OT-1 splenocytes were cultured with increasing numbers of irra-
line), and ss-OVApTAP8 (bold black line). Similar results were ob-diated splenocytes from the following mice: ss-OVATAP8 (circles),
tained 4 and 7 days post transfer.B6 (triangles), ss-R4TAP8 line 1 (open diamonds), ss-R4TAP8 line 2
(filled diamonds), and ss-VSVTAP8 (squares). The assay was pulsed
with [3H]thymidine for 18 hr after 36 hr of culture.
(D) OT-1 CTL were used at the indicated effector to target ratio with
cells that had been transferred into the host expressing51Cr-labeled Con A blasts as targets made from the following mice:
ss-OVAp).ss-OVATAP8 (circles), TAP8 (triangles), ss-R4TAP8 line 1 (open dia-
monds), and ss-VSVTAP8 (squares). Prior to transfer, OT-1 CD81 T cells were 92% CD44lo
and 96% CD62Lhi and were negative for CD25 and
CD49d, typical of naive lymphocytes (data not shown).
The OT-1 T cells that had proliferated in the ss-OVApnot proliferate when transferred into unirradiated ss-
mice upregulated expression of CD44, while the nondi-R4TAP1 hosts, and we saw no evidence of immune-
viding cells in the TAP8 hosts remained CD44lo (Figuremediated tissue damage in ss-R4 hosts compared to
5B). OT-1 cells transferred into the B6 or ss-R4TAP8ss-OVAp hosts, which had obvious symptoms of GVH
disease, following OT-1 transfer (data not shown). These mice expressed CD44 at levels intermediate to donor
findings indicate that ss-R4 is not acting as a conven- cells in TAP8 and ss-OVAp recipients. However, the OT-1
tional antigen in vivo. T cells proliferating in B6 and ss-R4TAP8 maintained
a naive phenotype for the other activation markers ana-
lyzed. OT-1 cells, which had encountered an antigenicOT-1 Cells Proliferating in Irradiated Syngeneic
ligand in the ss-OVAp mice, upregulated expression ofHosts Are Phenotypically Distinct from Those
CD25 and CD49d and downregulated CD62L in a man-that Have Encountered Cognate Antigen
ner characteristic of fully activated effector cells. TheNext, we characterized the activation state of the OT-1
cells proliferating in the B6 or ss-R4TAP8 hosts remainedcells that were proliferating in irradiated B6 and ss-
low for expression of CD25 and CD49d and high forR4TAP8 hosts. OT-1 CD81 T cells were phenotyped for
CD62L as did the nondividing cells in the TAP8 host, aexpression of activation markers on day 6 after transfer
phenotype typical of naive cells. Similar results wereinto different hosts (Figure 5). Cells transferred into irra-
seen at days 4 and 7 following transfer (data not shown).diated TAP8 hosts did not divide, while cells transferred
Thus, the cells that undergo proliferation upon transferinto ss-OVApTAP8 hosts went through more than eight
into irradiated recipients expressing only self or antago-divisions, losing all of their CFSE label (Figure 5A). OT-1
nist ligands have a phenotype distinct from both naivecells transferred into irradiated B6 or ss-R4TAP8 hosts
and effector cells, suggesting a state of partial acti-proliferated at a similar rate, with most of the cells hav-
ing divided 2±5 times in 6 days (more slowly than the vation.
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stimulate effector functions (Jameson et al, 1993; Barn-
den et al., 1994). In fetal thymic organ culture, the R4
peptide restores positive selection of OT-1 double-posi-
tive thymocytes in MHC class I±deficient cultures (Hog-
quist et al., 1994). The binding of the OT-1 TCR to the
OVAp/Kb agonist ligand has a Kd of 7.1 mM while binding
to the R4/Kb antagonist with a Kd of 53.6 mM, approxi-
mately 7-fold lower than the cognate ligand (Alam et al.,
1996). Thus, we demonstrate here that peptide/MHC
complexes, which are of low affinity for the TCR and are
not conventional antigens, can nevertheless stimulate
proliferation of mature T cells in vivo when lymphocyte
Figure 6. OT-1 Cells Proliferating in Irradiated B6 and ss-R4TAP8 numbers are decreased.
Mice Do Not Become Cytotoxic Effector Cells
The signal for proliferation in irradiated B6 hosts is
CD81Va21 cells (2 3 106) from OT-1 RAG8 mice were CFSE labeled
delivered by self-peptide/MHC complexes. We proposeand injected into irradiated B6 (triangles), ss-R4TAP8 (diamonds),
that a ligand similar to R4, in terms of its affinity for theor ss-OVApTAP8 (circles) hosts. Spleen cells were harvested on day
OT-1 TCR, exists in wild-type B6 mice, and that this4 and assayed for lysis of OVAp-coated EL4 targets. Flow cytometry
revealed that transferred OT-1 Va21CD81 cells represented 15%, ligand (or ligands) is responsible for the positive selec-
6%, and 75% of splenocytes recovered from B6, ss-R4TAP8, or ss- tion of OT-1 thymocytes and for the peripheral expan-
OVApTAP8 hosts, respectively (data not shown). The E:T was based sion of mature OT-1 T cells in a T cell depleted environ-
on the number of CD81Va21 cells used as effectors. The wells were ment. We show that such proliferation is absent in TAP8
normalized for total cell number by diluting cells recovered from
hosts, which have low levels of self-peptide/MHC com-B6 (triangles) and ss-OVApTAP8 hosts (filled circles) with fresh B6
plexes (Figures 1 and 3). The trigger for proliferation issplenocytes to 6% CD81Va21 cells, or cells recovered from ss-
restored by expression of an antagonist peptide, R4,OVApTAP8 hosts were used undiluted (open circles). For all effectors
at all E:T ratios, lysis of EL4 targets in the absence of peptide was which is presented by MHC class I in a TAP-independent
less than 3% (data not shown). manner (Figure 3). In ss-R4TAP8 mice, R4 is expressed
at very low levels, as indicated by the fact that the ex-
pression of MHC class I molecules is not upregulatedOT-1 CD81 T Cells Proliferating in Irradiated,
by the presence of the transgenic peptide (Figure 2A).Syngeneic Hosts Are Not Ex Vivo Effectors
A control peptide that binds the same class I moleculeWe next evaluated the functional status of OT-1 CD81 T
but has no detectable interaction with the OT-1 TCRcells that had been transferred into irradiated recipients.
does not support proliferation of transferred cells, show-Donor OT-1 CD81 T cells were used as effectors in a
ing the specificity of this interaction (Figure 3A).CTL assay 4 days after transfer into irradiated B6, ss-
It is surprising that we observe proliferation of T cellsR4TAP8, or ss-OVApTAP8 hosts. The OT-1 cells prolifer-
in response to an antagonist peptide, as antagonist li-ated extensively in ss-OVAp hosts, as seen by a low
gands have been identified by their ability to inhibit cyto-
level of CFSE1 cells among the Va21CD81 population,
lytic activity and proliferation in vitro (Evavold et al.,
and had undergone several rounds of division in the
1993; Jameson and Bevan, 1995). Recently, these
irradiated B6 and ss-R4TAP8 hosts (data not shown).
findings were confirmed in vivo when proliferation of
While OT-1 cells recovered from ss-OVAp hosts lysed transgenic cells to cognate antigen was inhibited by
peptide-pulsed targets efficiently, cells recovered from the expression of a TCR antagonist peptide in a full
the B6 and ss-R4TAP8 hosts showed no CTL activity lymphocyte compartment (Basu et al., 1998). Many an-
(Figure 6). Dilution of the cells recovered from ss-OVAp tagonist ligands have been shown to induce partial acti-
hosts with fresh B6 splenocytes (to normalize for total vation, such as cytokine release or killing without prolif-
numbers of cells) did not significantly inhibit lysis of eration, and are also known to mediate positive selection
peptide-pulsed targets, showing that the failure to de- of thymocytes, suggesting that they mediate a range of
tect lysis by the cells recovered from B6 and ss-R4TAP8 functions by T cells (Evavold et al., 1993; Jameson and
hosts was not due to the lower percentage of OT-1 cells Bevan, 1995). Nevertheless, our data clearly show that
in that population (Figure 6, filled circles). Therefore, efficient proliferation of mature CD81 T cells in lympho-
OT-1 cells proliferating in irradiated hosts are not ex penic hosts requires specific, low-affinity peptide li-
vivo CTL effectors. gands. We observe division of a very small number of
cells in TAP8 and ss-VSVTAP8 hosts (Figures 1, 3, and
Discussion 5). These cells may interact with the low levels of MHC
class I on TAP8 cells sufficiently to drive proliferation.
In this study we show that proliferation of mature CD81 Alternatively, the presence of these few dividing cells
T cells in lymphopenic hosts depends on the specific may suggest that an additional, MHC-independent
interaction of the TCR with MHC class I. The ligand mechanism exists that supports proliferation of lympho-
that drives this proliferation in the absence of cognate cytes when T cell numbers are reduced. It is important
antigen has low affinity for the TCR and has been pre- to note that this proliferation is not a radiation-specific
viously characterized as an antagonist peptide for the phenomenon, since it also occurs in mice that have been
T cells (Jameson et al., 1993; Alam et al., 1996, 1999). depleted of peripheral T cells by injection of anti-Thy1
In previous in vitro studies, we have shown that the R4 antibody (Figure 1).
variant of the OVA agonist peptide can antagonize the Interestingly, the signal that mediates positive selec-
tion and allows developing thymocytes to survive andresponse of effector OT-1 cells but has no ability to
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escape programmed cell death is thought to be provided competition for peptide/MHC complexes would explain
by self-peptide/MHC complexes that serve as antago- the ability of T cells to proliferate in response to self-
nists for effector cells (Hogquist et al., 1994; Jameson peptide/MHC ligands for at least two reasons. First, it
et al., 1995). These ligands are thought to provide partial has been shown that CD4 and CD8 compartments can
signals via the TCR (Sloan-Lancaster et al., 1994; Sousa compensate for each other (for instance, in MHC class
et al., 1996; Jameson and Bevan, 1995). Previously, it II±deficient mice, CD8 T cells compensate for the total
was thought that self-peptide/MHC ligands are not sig- number of T cells), suggesting that homeostasis of the T
nificantly perceived by mature T cells in the periphery. cell compartment is based on total lymphocyte number
However, experiments published recently by several (Tanchot et al., 1997b). Second, proliferation of a small
groups have shown an important role for MHC in the number of CD4 T cells in a lymphopenic host can be
maintenance of both CD41 and CD81 T cells. In the inhibited by cotransfer of a large number of CD8 T cells
absence of the restricting MHC allele, CD41 and CD81 and vice versa (Ernst et al., 1999). Otherwise, T cells
T cells are unable to survive for prolonged periods of could compete for non-MHC derived stimulatory signals
time (Brocker, 1997; Kirberg et al., 1997; Rooke et al., such as growth factors that would promote their ability
1997; Takeda et al., 1996; Tanchot et al., 1997a; Nesic to receive a stimulus from self-peptide/MHC, allowing
and Vukmanovic, 1998; Viret et al., 1999). New data proliferation. (2) In a second scenario, T cells may
presented here for CD81 T cells and by Viret et al. and ªsenseº the levels of lymphocytes and regulate the lym-
Ernst et al. for CD41 T cells show an important role for phocyte pool. This could work directly through T cell±
specific peptide/MHC complexes in supporting prolifer- T cell interactions; cell contact would inhibit prolifera-
ation of T cells when lymphocyte numbers are reduced tion or decrease sensitivity to TCR signals. Alternatively,
(Ernst et al., 1999; Viret et al., 1999). Together, these data T cell number could regulate a second cell type such
highlight a more central role for low-affinity interactions as APC, which would influence the sensitivity of T cells
between the TCR of peripheral T cells and self-peptide/ to TCR/MHC interactions. (3) Finally, T cell loss could be
MHC in regulating homeostasis of peripheral T cell pop- detected by another cell type that would in turn cause
ulations. the upregulation of a ligand or factor that could promote
We show that OT-1 cells recovered from irradiated T cell division upon TCR/MHC engagement with low-
B6 and ss-R4TAP8 hosts have no ex vivo CTL activity, affinity ligands. While the homeostatic mechanisms that
while cells transferred into antigen-expressing mice be- control peripheral T cell proliferation are not understood,
come potent CTL (Figure 6). This finding appears to data presented here show that TCR/MHC interactions
contradict a recent report by Oehen and coworkers are essential for this process to occur when the T cell
which suggests that CD81 T cells, specific for lympho- pool is depleted. Similar mechanisms may regulate the
cytic choriomeningitis virus (LCMV), proliferating in low levels of division normally observed by naive T cells
lymphopenic hosts can differentiate into effector cells. within a full lymphocyte compartment.
Their conclusion is based on the finding that these cells
are at an advantage in eliminating LCMV when com- Experimental Procedures
pared to naive T cells (Oehen and Brduscha-Riem, 1999).
MiceHowever, no ex vivo CTL activity was shown for these
All mice were maintained in a specific pathogen-free facility. OT-1cells in this study. We suggest that due to the partially
TCR transgenic mice, which express transgenes encoding a Va2,activated phenotype of cells undergoing division in
Vb5 TCR specific for an octomeric peptide derived from ovalbuminlymphopenic hosts, a faster or more efficient response
(OVAp) presented by H2-Kb (Hogquist et al., 1994), were bred to
can be elicited in their system, but that the cells are not C57BL/6 (B6), RAG8 (129 3 B6), or B6.PL Thy1a/Cy (Thy1.11) mice.
effectors in the absence of conventional antigen. We Mice expressing transgenes encoding H2-Kb binding peptides pre-
also show that proliferating cells display a partially acti- ceded by an endoplasmic reticulum signal sequence (ss) to allow
for TAP-independent presentation of the transgene-encoded pep-vated surface phenotype, suggesting that they are not
tide (ss-peptide) were generated as follows. An expression cassettemature effectors. The cells upregulate CD44 levels as
including a 4 kb fragment of the MHC class I promoter and a multipledo antigen-stimulated cells, but they retain a naive phe-
cloning site followed by 0.8 kb of SV40 intron and polyadenylationnotype for CD25, CD49d, and CD62L (Figure 5). This sequences was provided by Dr. Dimitris Kioussis (Jat et al., 1991).
observation is of interest, as CD44 has been widely used H2-Kb-binding peptides were expressed with the endoplasmic retic-
as a marker for memory cells. Thus, we show prolifera- ulum insertion signal sequence derived from mouse b2-microglobu-
tion of naive cells without the acquisition of a true ef- lin at the amino termini. Constructs were generated to encode one
of three H2-Kb-binding peptides, OVAp, R4, and VSV. TAP-deficientfector or memory phenotype.
RMA-S cells transfected with these constructs served as targetsHow a T cell measures the affinity between its TCR
for peptide-specific CTL, indicating appropriate expression and pro-and a given ligand and then translates that measurement
cessing of the Kb-binding peptides (data not shown). Vector se-
into a cellular readout (i.e., proliferation, differentiation) quences were removed by digestion with ClaI and NotI, and the
is unknown. However, the fact that T cells proliferate constructs were injected into (H-2b 3 H-2d)F2 fertilized mouse
significantly in response to low-affinity/self ligands when eggs. Multiple founders for each construct were bred to TAP8 mice
T cell numbers are reduced demonstrates that this pro- (129 3 B6).
Host mice were irradiated (650 cGy) 2 days prior to adoptivecess can be altered by global homeostatic signals. We
transfer or were given 75 mL of anti-Thy1.2 (30H12) ascites for 3can envision at least three different mechanisms by
consecutive days starting 10 days prior to adoptive transfer. Donorwhich this could work. (1) Competition for niches or
OT-1 CD81 T cells were pooled from spleen and lymph node and
space would be reduced when T cell numbers are de- were of RAG8 or Thy1.1 origin where indicated. OT-1 CD81 RAG1
pleted, allowing greater accessibility to specific peptide/ and OT-1 CD81 Thy1.11 donor cells were enriched by purification
MHC ligands or growth factors that promote division. over nylon wool columns followed by depletion of HSA1 cells with
J11D antibody plus complement lysis. Transferred cells were .70%However, we think it is unlikely that a decrease in direct
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